Reproductive justice in the time of COVID-19: a systematic review of the indirect impacts of COVID-19 on sexual and reproductive health

TI Mukherjee, AG Khan, A Dasgupta, G Samari - Reproductive health, 2021 - Springer
Objective Despite gendered dimensions of COVID-19 becoming increasingly apparent, the
impact of COVID-19 and other respiratory epidemics on women and girls' sexual and …

Effectiveness, safety and acceptability of no‐test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study

ARA Aiken, PA Lohr, J Lord, N Ghosh… - BJOG: An International …, 2021 - Wiley Online Library
Objective To compare outcomes before and after implementation of medical abortion
(termination of pregnancy) without ultrasound via telemedicine. Design Cohort analysis …

Looking ahead in the COVID-19 pandemic: emerging lessons learned for sexual and reproductive health services in low-and middle-income countries

A Banke-Thomas, S Yaya - Reproductive health, 2021 - Springer
The COVID-19 pandemic has caused widespread disruption to essential health service
provision globally, including in low-and middle-income countries (LMICs). Recognising the …

[HTML][HTML] Abortion safety and use with normally prescribed mifepristone in Canada

L Schummers, EK Darling, S Dunn… - … England Journal of …, 2022 - Mass Medical Soc
Abstract Background In the United States, mifepristone is available for medical abortion (for
use with misoprostol) only with Risk Evaluation and Mitigation Strategy (REMS) restrictions …

First dose of misoprostol administration at home or in hospital for medical abortion between 12–22 gestational weeks in Sweden (PRIMA): a multicentre, open-label …

J Rydelius, H Hognert, H Kopp-Kallner, K Brandell… - The Lancet, 2024 - thelancet.com
Background Medical abortion after 12 gestational weeks often requires a stay in hospital.
We hypothesised that administering the first misoprostol dose at home could increase day …

How can patient experience of abortion care be improved? Evidence from the SACHA study

M Lewandowska, R Scott, R Meiksin… - Women's …, 2024 - journals.sagepub.com
Background: Models of abortion care have changed significantly in the last decade, most
markedly during the COVID-19 pandemic, when home management of early medical …

[HTML][HTML] Real-time effects of payer restrictions on reproductive healthcare: a qualitative analysis of cost-related barriers and their consequences among US abortion …

JA Higgins, M Lands, TM Valley, E Carpenter… - International Journal of …, 2021 - mdpi.com
Objective: The Hyde Amendment and related policies limit or prohibit Medicaid coverage of
abortion services in the United States. Most research on cost-related abortion barriers relies …

The perspective of Canadian health care professionals on abortion service during the COVID-19 pandemic

M Ennis, K Wahl, D Jeong, K Knight, R Renner… - Family …, 2021 - academic.oup.com
Background The COVID-19 pandemic and pandemic response created novel challenges for
abortion services. Canada was uniquely positioned to transition to telemedicine because …

Improving experience of medical abortion at home in a changing therapeutic, technological and regulatory landscape: a realist review

P Baraitser, C Free, WV Norman, M Lewandowska… - BMJ open, 2022 - bmjopen.bmj.com
Objective To inform UK service development to support medical abortion at home,
appropriate for person and context. Design Realist review Setting/participants Peer …

Telemedicine for the provision of medication abortion to pregnant people at up to twelve weeks of pregnancy: a systematic literature review and meta-analysis

L Cely-Andrade, K Cárdenas-Garzón… - Reproductive …, 2024 - Springer
Background Telemedicine represents an important strategy to facilitate access to medication
abortion (MAB) procedures, reduces distance barriers and expands coverage to …